To test this model that NRF2 plays an important role in the promotion of G12Ci-induced anti-cancer immunity, we treated WT and Keap1-Nrf2 DKO cells with G12Ci and measured NISP chemokine gene induction in cells without a KRASG12C mutation. This evidence concerns the gene NFE2L2 and cancer.